Revium Rx (RVRC) Enterprise Value (2024 - 2026)

Revium Rx (RVRC) posted Enterprise Value of -$2.7 million for Q4 2025, up 39.88% sequentially from -$4.5 million in Q4 2024, and up 39.88% YoY from -$1.9 million in Q4 2024.

Revium Rx (RVRC) Enterprise Value (2024 - 2026) Analysis & Trends

Revium Rx has reported Enterprise Value for 2 years, with the latest figure at -$2.7 million in Q4 2025.

  • Quarterly Enterprise Value rose 39.88% year-over-year to -$2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.7 million (up 39.88% YoY) and the FY2025 annual result came in at -$2.7 million, up 39.88% from the prior year.
  • Enterprise Value advanced to -$2.7 million in Q4 2025 per RVRC's latest filing, from -$4.5 million in the prior quarter.
  • Over five years, Enterprise Value peaked at -$2.7 million in Q4 2025 and troughed at -$4.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -7.31 Bn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn -552.56 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn -265.37 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -552.03 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -389.39 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -298.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn -191.60 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -687.79 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -374.99 Mn
10 Revium Rx 101.42 Mn 99.91 Mn - -1.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.51 Mn
Dec 31, 2025 -2.71 Mn
Dec 31, 2024 -4.51 Mn